Psilocybin Alpha's free 100-page report: Psychedelics 2021

Josh Hardman of the excellent Psilocybin Alpha writes of this very interesting, freely downloadable PDF: "This report includes - * A deep dive into psychedelic drug policy reform efforts and successes in 2021, with a focus on key jurisdictions including the U.S. and Canada. * A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. * Coverage of investments into both public and private psychedelics ventures in 2021, with thematic analysis and a look at key company highlights. * An overview of psychedelics in popular culture last year, plus a discussion of just two controversies that erupted in 2021. * In the final section we share the key trends we will be following as we look ahead to 2022. There's no two ways about it: this is a text-heavy long-read: apologies in advance for those that prefer their media diet to be a little more visual. But, readers should find light relief in the occasional chart, graph and case study."

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

Psychedelics offer new route to recovery from eating disorders

Next
Next

Repeated low doses of LSD in healthy adults: A placebo-controlled, dose–response study